FDA Warns Consumers about Counterfeit Alli : RushPRNews - Newswire & Global Press Release Distribution

 
Bookmark and Share

FDA Warns Consumers about Counterfeit Alli

January 19, 2010

Washington, DC (RPRN) 01/19/10 — The counterfeit products contain controlled substance sibutramine

The U.S. Food and Drug Administration is today warning consumers about a counterfeit and potentially harmful version of Alli 60 mg capsules (120 count refill kit).

Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.

Consumers began reporting suspected counterfeit Alli to GSK in early December 2009. GSK has determined that the counterfeit product has been sold over the internet. However, there is no evidence at this time that the counterfeit Alli product has been sold through other channels, such as retail stores.

The counterfeit Alli product looks similar to the authentic product, with a few notable differences. The counterfeit Alli has:

Outer cardboard packaging missing a “Lot” code;

Expiration date that includes the month, day, and year (e.g., 06162010); authentic Alli expiration date includes only the month and year (e.g.,: 05/12);

Packaging in a plastic bottle that has a slightly taller and wider cap with coarser ribbing than the genuine product;

Plain foil inner safety seal under the plastic cap without any printed words; the authentic product seal is printed with “SEALED for YOUR PROTECTION”;

Contains larger capsules with a white powder, instead of small white pellets.

Consumers who believe they have received counterfeit Alli are asked to contact the FDA's Office of Criminal Investigations (OCI) by calling 800-551-3989 or by visiting the OCI Web site (http://www.fda.gov/OCI).

Health care professionals and consumers are encouraged to report adverse events that may be related to the use of these counterfeit products to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by fax at 1-800-FDA-0178, or by mail at: MedWatch, HF-2, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787.

 

Media Web Address: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197857.htm
About the author:

FDA is an agency within the Department of Health and Human Services and consists of seven centers and offices

Click here to see all news from this author/company

Filed Under: FDA- Pharmaceutical news, Health and Fitness, Lifestyle, PRESS RELEASE

RUSH PR NEWS newswire and press release services at rushprnews.com / Anne Howard annehowardpublicist.com

Content- Legal Responsibility - All material is copyrighted - You may repost but you MUST link back to the original post on your page and acknowledge Rush PR News as the news source. Rush PR News is not legally and/or morally responsible for content of press releases, opinions expressed or fact-checking.

Rush PR News cannot be held legally responsible for material published and distributed through its newswire service or published in its press-room and therefore cannot be sued for published material. Third-party must be contacted directly to dispute content.

Rush PR News is not the contact for material published.

RSSFeed PRESS & SOCIAL MEDIA RELEASES

Cancer Drug Developer GeneSegues Therapeutics Names Laura Morris Brod as CEO

MINNEAPOLIS, MN 10/29/14 · Company Positioned to Accelerate Growth Plans GeneSegues Therapeutics, a...

Una solución moderna de tratamiento para el cáncer de seno

Miami, FL 10/29/14 · - Innovative Cancer Institute de South Miami, Florida,...

Cody Bollerman Digital Poised To Shake Things Up In The Business Consulting And Digital Marketing Sectors

San Diego,Calif. 10/24/14 · SAN DIEGO-BASED CODY BOLLERMAN DIGITAL POISED TO SHAKE THINGS UP...

UK’s first night job site launches

London, UK 10/24/14 · Night jobs search service launched in the United...

Bloody Good Tv Runs $10,000 Horror Movie Watching Contest On PublicVine

Florence, Alabama 10/24/14 · This Halloween, consumers can register to win up...

Ultraseal International aiming for hat-trick

Coventry, West Midlands 10/23/14 · Ultraseal International, a global leader in finding solutions...

Newborn Foundation Co-Convenes Shanghai Symposium with Focus on Congenital Heart Disease in Newborns and Infants

Saint Paul, MN / Shanghai, China 10/20/14 · Expansion of Newborn Screening Program & Latest Data...

Ste. Anne's New Fitness Centre In An Idyllic Setting

GRAFTON, ONTARIO 10/17/14 · -Maison Sante is just one part of Ste. Anne's...

Newborn Foundation Honors Leaders in Newborn Health, Technology, Policy and Advocacy at 2014 Awards Gala

Minneapolis, MN 10/13/14 · – The Newborn Foundation, an international nonprofit leveraging...

Phaedra Beauty Cosmetics Re-Launches with New Packaging

Los Angeles, CA 10/13/14 · Hollywood celebrity make-up artist Phaedra L. Williams introduces...

Indie Film, The Ballad of Snake Oil Sam 2014 Global Film Festival Tour

Los Angeles, CA 10/13/14 · Indie Film, The Ballad of Snake Oil Sam...

Newborn Health & Technology Leader Dr. Terese Finitzo Receives ‘Eve Award’ for Innovation

MINNEAPOLIS, MN 10/10/14 · Newborn Foundation Awards Gala honors global leaders in...